logo
Dorian LPG (LPG): Among the Energy Stocks that Gained This Week

Dorian LPG (LPG): Among the Energy Stocks that Gained This Week

Yahoo3 days ago
The share price of Dorian LPG Ltd. (NYSE:LPG) surged by 9.17% between July 7 and July 11, 2025, putting it among the Energy Stocks that Gained the Most This Week.
An aerial view of a VLGC docked in port, surrounded by cranes and roadways.
Dorian LPG Ltd. (NYSE:LPG) is a liquefied petroleum gas shipping company and a leading owner and operator of modern very large gas carriers.
As of the close of July 11th, Dorian LPG Ltd. (NYSE:LPG) has gained more than 25% over the last month following a recovery in the global energy industry, particularly due to a tariff truce between China and the United States. American LPG specifications are particularly attractive for Chinese PDH plants, so the recent trade developments between the two countries mark a strong tailwind for the industry.
Dorian LPG Ltd. (NYSE:LPG) remains bullish on the future of the industry, with Chairman and CEO John Hadjipateras stating in the company's Q4 earnings call:
"We are confident in the long-term fundamentals of LPG demand, which are underpinned by growing petrochemical and residential consumption, particularly in Asia and by infrastructure expansions in the U.S., which will support steady growth in NGL output."
Despite falling short on estimates in both profits and revenue, Dorian LPG Ltd. (NYSE:LPG) announced a dividend of $0.50 per share in May, totaling $21.3 million, reflects its commitment to returning capital to shareholders.
While we acknowledge the potential of LPG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the .
READ NEXT: 10 Best Nuclear Energy Stocks to Buy Right Now and The 5 Energy Stocks Billionaires are Quietly Piling Into.
Disclosure: None.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Home BancShares Inc (HOMB) Q2 2025 Earnings Call Highlights: Record Earnings and Strategic ...
Home BancShares Inc (HOMB) Q2 2025 Earnings Call Highlights: Record Earnings and Strategic ...

Yahoo

time24 minutes ago

  • Yahoo

Home BancShares Inc (HOMB) Q2 2025 Earnings Call Highlights: Record Earnings and Strategic ...

Total Assets: Almost $23 billion. Market Capitalization: Just short of $6 billion. Record Earnings: $118.4 million or $0.60 earnings per share. Return on Assets (ROA): 2.08%. Non-GAAP Return on Tangible Common Equity (ROTCE): 18.26%. Tier One Capital Ratio: 15.6%. Leverage Ratio: 13.4%. Total Risk-Based Capital: 19.3%. Tangible Common Equity Growth: 11.25% over the past 12 months. Stock Buybacks: $1 million shares bought back in both Q1 and Q2. Quarterly Dividends: $0.20 per share. Net Interest Margin: 4.44%. Adjusted Return on Assets: 2.02%. Adjusted Efficiency Ratio: 42.01%. Loan Recoveries: $2 million recovered this quarter. CCFG New Commitments: Approximately $500 million in Q2. CCFG Portfolio Growth: $122 million increase during the quarter. Warning! GuruFocus has detected 2 Warning Sign with HOMB. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Home BancShares Inc (NYSE:HOMB) reported record earnings of $118.4 million or $0.60 per share, marking a consistent performance with a return on assets of 2.08%. The company has demonstrated strong financial growth, with tangible common equity increasing by 11.25% over the past 12 months. Home BancShares Inc (NYSE:HOMB) has been aggressive in stock buybacks, purchasing 2 million shares so far this year, which adds value for shareholders. The company has maintained a strong balance sheet with a Tier One capital ratio of 15.6% and a total risk-based capital of 19.3%. The Centennial Commercial Finance Group (CCFG) saw significant portfolio growth, closing approximately $500 million in new commitments for the quarter. Negative Points Deposits ended slightly lower in Q2, down $53 million due to seasonal tax payments, although balances grew in May and June. There is ongoing pressure from competition offering lower rates, which could impact loan growth and profitability. The company is facing challenges in resolving a large non-accrual loan related to a yacht, which is currently in the arrest process. Home BancShares Inc (NYSE:HOMB) is actively seeking acquisitions to boost income, indicating potential challenges in achieving organic growth targets. Expenses were elevated this quarter due to a $3.5 million lawsuit settlement, impacting overall financial performance. Q & A Highlights Q: Can you provide insights into the strong loan growth this quarter and the factors driving it? A: Kevin D. Hester, President and Chief Lending Officer, explained that the growth is not due to increased aggressiveness but rather the result of being in strong markets with good opportunities. The company is taking advantage of what the market offers, despite some competition locking in lower rates prematurely. Q: What are your current thoughts on M&A opportunities, and are you considering acquiring loan assets or whole banks? A: John W. Allison, Chairman and CEO, stated that they are primarily looking at whole bank acquisitions rather than just loan assets. They are exploring several opportunities and aim to find deals that are accretive and make sense for the company. Q: How do you view the potential for a triple accretive deal in the current market environment? A: John W. Allison emphasized that they have historically avoided dilution and are cautious about pursuing deals that would require it. They aim for accretive transactions and are not interested in deals that would dilute shareholder value. Q: Can you discuss the current deposit pricing trends and any pressures you are experiencing? A: Stephen Tipton, CEO of Centennial Bank, noted that deposit pricing pressures remain similar to the previous quarter. They are managing to negotiate competitive rates and are optimistic about reducing costs on maturing CDs in the second half of the year. Q: What are your plans regarding stock buybacks, especially in light of current valuations? A: John W. Allison mentioned that they continue to buy back stock and are considering a special dividend for shareholders. They are evaluating the buyback yield and its impact on shareholder value, and any decision will depend on capital needs for potential acquisitions. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.

Elevance Health Inc (ELV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost ...
Elevance Health Inc (ELV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost ...

Yahoo

time24 minutes ago

  • Yahoo

Elevance Health Inc (ELV) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost ...

GAAP Diluted EPS: $7.72 for the second quarter. Adjusted Diluted EPS: $8.84 for the second quarter. Full Year 2025 Adjusted EPS Guidance: Approximately $30. Operating Revenue: $49.4 billion, a 14% increase year-over-year. Benefit Expense Ratio: 88.9%, an increase of 260 basis points year-over-year. Medical Membership: 45.6 million, down approximately 200,000 sequentially. Adjusted Operating Expense Ratio: 10.0%, improved by 140 basis points year-over-year. CarelonRx Revenue Growth: Over 20% increase. Carelon Services Revenue Growth: Greater than 50% increase. Debt-to-Capital Ratio: 40.8% at the end of the quarter. Operating Cash Flow: $2.1 billion for the quarter; approximately $6 billion expected for the full year. Capital Return to Investors: Approximately $2 billion year-to-date. Warning! GuruFocus has detected 3 Warning Sign with PEP. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Elevance Health Inc (NYSE:ELV) reported a 14% year-over-year increase in operating revenue, reaching $49.4 billion, driven by higher premium yields and recent acquisitions. The company delivered adjusted EPS consistent with expectations, reflecting strength in the Medicare Advantage portfolio and disciplined cost management. CarelonRx and Carelon services showed strong performance, with CarelonRx growing operating revenue by over 20% and Carelon services delivering more than 50% growth in revenue. Elevance Health Inc (NYSE:ELV) is actively using AI-enabled tools to streamline clinical workflows and improve operational efficiency. The company is expanding its value-based care portfolio, particularly in behavioral health and oncology, with more than one-third of benefit expenses now in downside risk arrangements. Negative Points Elevance Health Inc (NYSE:ELV) revised its full-year 2025 adjusted EPS guidance to approximately $30, reflecting pressures from elevated medical cost trends in ACA and slower Medicaid rate alignment. The company experienced a sequential decline in medical membership, down approximately 200,000, primarily due to reductions in Medicaid membership and lower effectuation rates in the ACA business. The consolidated benefit expense ratio increased by 260 basis points year-over-year, driven by ACA and Medicaid businesses. Elevance Health Inc (NYSE:ELV) is facing challenges with elevated medical cost trends due to increased morbidity in the ACA market and higher acuity from Medicaid redeterminations. The company anticipates a prolonged Medicaid margin recovery period due to slower-than-expected rate adjustments aligning with current cost levels. Q & A Highlights Q: Can you help delineate the pressure you're seeing in the ACA business between unit cost trends and shifts in the risk pool? And how is your expectation for risk adjustment unchanged given the higher morbidity? A: Mark Kaye, CFO, explained that the ACA business is experiencing increased medical trends due to three factors: a rise in risk pool acuity and morbidity, higher utilization in several cost categories, and aggressive coding tactics by some providers. The risk adjustment expectation remains unchanged because the uptick in member acuity is driven by a broader market-wide trend, not a shift in Elevance's membership mix. Q: Can you size the relative impact of ACA and Medicaid on the guidance revision? And how challenging is it to reprice for the public exchanges? A: Gail Boudreaux, CEO, stated that the guidance revision is slightly more weighted towards ACA. The company has embedded a more elevated morbidity profile into its forecast and expects a broader market reset in 2026. In Medicaid, they anticipate a gradual alignment to rates due to ongoing enrollment losses and constructive discussions with states. Q: How do you address the concern of being continually underpaid in Medicaid due to disconnects in forward trend? A: Gail Boudreaux emphasized that Elevance is working closely with states to ensure rates reflect member acuity. The company expects a gradual alignment over a couple of rate cycles and is using actuarially sound data to support discussions with states. Q: What are you seeing in Medicare Advantage trends, and how are you approaching bids for 2026? A: Gail Boudreaux noted that Medicare Advantage trends remained consistent with expectations. Felicia Norwood, President of Government Health Benefits, added that the company is taking a disciplined approach to bids, focusing on sustainable long-term value and margin recovery. Q: What are you doing differently in terms of cost structure initiatives for the rest of the year and into next year? A: Gail Boudreaux highlighted ongoing efforts to simplify and automate processes using technology, leveraging AI to identify cost trends early, and addressing billing abnormalities. The company is also focusing on areas like ER utilization and specialty services to improve affordability. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

SL Green Realty Corp (SLG) Q2 2025 Earnings Call Highlights: Strong Leasing Activity and ...
SL Green Realty Corp (SLG) Q2 2025 Earnings Call Highlights: Strong Leasing Activity and ...

Yahoo

time24 minutes ago

  • Yahoo

SL Green Realty Corp (SLG) Q2 2025 Earnings Call Highlights: Strong Leasing Activity and ...

Leasing Activity: Over 540,000 square feet leased in Q2, totaling 1.3 million square feet year-to-date. Pipeline: Over 1 million square feet for near-term execution, with 80% of leases under 25,000 square feet. Investment Profit: Nearly $90 million profit on a $130 million investment in the 522 mortgage position. Cash Proceeds: Over $300 million from the 522 transaction and 625 Madison Avenue interest sale. Fund Commitments: Over $500 million closed in Q2, totaling over $1 billion to date. Corporate Liquidity: Over $2 billion in liquidity and fund availability. Earnings Guidance: Raised by $0.40 per share at the midpoint. FFO Guidance Increase: $0.40 or 7.4% increase at the midpoint. Incremental FFO: $0.69 per share from 522 Fifth mortgage repayment. Interest Expense: Trending $0.10 per share above original expectations. NOI Performance: Slightly better than original expectations. Summit Attendance: Higher than projections in Q2, on target for the first six months. Discounted Debt Gains: Potential for gains larger than the $20 million currently in guidance. Warning! GuruFocus has detected 8 Warning Signs with SLG. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points SL Green Realty Corp (NYSE:SLG) achieved over 540,000 square feet of leasing in the second quarter, bringing the year-to-date total to 1.3 million square feet. The company successfully monetized its investment in the 522 Fifth Avenue mortgage position, realizing nearly $90 million of profit on a $130 million investment. SL Green Realty Corp (NYSE:SLG) raised its earnings guidance at the midpoint by $0.40 per share, reflecting increased profitability. The company closed over $500 million of fund commitments, bringing the total to over $1 billion, enhancing corporate liquidity. SL Green Realty Corp (NYSE:SLG) is actively pursuing a casino license bid for Caesars Palace Times Square, which could significantly boost tax revenue and local business without displacing residents. Negative Points There was a slight dip in occupancy in the second quarter, which surprised the market. Interest expense is trending above original expectations by about $0.10 per share, primarily due to decisions around potential asset sales. The company's other income line item saw a $15 million quarter-over-quarter decline, attributed to less fee income. The unpredictability and lumpiness of income streams make modeling the company's financials complex. Concerns were raised about potential political changes in New York City affecting the business environment, although no immediate impact on tenant discussions was noted. Q & A Highlights Q: The market was surprised by a slight dip in occupancy in the second quarter. Can you explain the pipeline and any known move-outs that could affect your ability to hit the 93.2% leased occupancy by the end of the year? A: Marc Holliday, CEO, explained that the dip was due to an unbudgeted tenant default at 711 Third Avenue. He emphasized that the leasing volume remains strong, with a pipeline of 1 million square feet and reiterated confidence in hitting the year-end occupancy target. Q: Regarding the gain at 522 Fifth Avenue, did you expect it to be monetized so quickly, and why was the investment disclosure not found on your balance sheet? A: Marc Holliday, CEO, stated that while the rapid resolution was faster than expected, it was within the range of outcomes. Matthew Diliberto, CFO, explained that the investment was a CMBS investment, which does not receive the same disclosure as the preferred equity portfolio. Q: Have you noticed any change in tenant discussions since the primary elections, and is it impacting leasing decisions? A: Marc Holliday, CEO, confirmed that there has been no impact on tenant negotiations or leasing decisions due to the primary elections. Q: Can you provide more color on the strengthening demand in Midtown and its impact on investment opportunities and rent growth? A: Marc Holliday, CEO, noted that tenant demand is increasing, especially in areas like Third Avenue, due to the high costs in core Midtown. This demand, coupled with limited new supply, is expected to drive rent growth and investment opportunities. Q: How does the plan to freeze rent impact the underwriting for office-to-residential conversions? A: Marc Holliday, CEO, explained that the proposal primarily affects stabilized units and is not applicable to free market and affordable housing. He noted that SL Green does not have investments in the rent-stabilized sector, so the impact is negligible for the company. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store